Hawlitschka A - Search Results

1

Transmembrane protein 119 is neither a specific nor a reliable marker for microglia.

Vankriekelsvenne E, Chrzanowski U, Manzhula K, Greiner T, Wree A, Hawlitschka A, Llovera G, Zhan J, Joost S, Schmitz C, Ponsaerts P, Amor S, Nutma E, Kipp M, Kaddatz H. Vankriekelsvenne E, et al. Among authors: hawlitschka a. Glia. 2022 Jun;70(6):1170-1190. doi: 10.1002/glia.24164. Epub 2022 Mar 4. Glia. 2022. PMID: 35246882

2

Effects of systemic PSI administration on catecholaminergic cells in the brain, adrenal medulla and carotid body in Wistar rats.

Hawlitschka A, Haas SJ, Schmitt O, Weiss DG, Wree A. Hawlitschka A, et al. Brain Res. 2007 Oct 10;1173:137-44. doi: 10.1016/j.brainres.2007.07.072. Epub 2007 Aug 14. Brain Res. 2007. PMID: 17850771

3

Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.

Wree A, Mix E, Hawlitschka A, Antipova V, Witt M, Schmitt O, Benecke R. Wree A, et al. Among authors: hawlitschka a. Neurobiol Dis. 2011 Feb;41(2):291-8. doi: 10.1016/j.nbd.2010.09.017. Epub 2010 Oct 16. Neurobiol Dis. 2011. PMID: 20955797

4

Intracerebrally applied botulinum neurotoxin in experimental neuroscience.

Hawlitschka A, Antipova V, Schmitt O, Witt M, Benecke R, Mix E, Wree A. Hawlitschka A, et al. Curr Pharm Biotechnol. 2013;14(1):124-30. Curr Pharm Biotechnol. 2013. PMID: 23092264 Review.

5

Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.

Antipova V, Hawlitschka A, Mix E, Schmitt O, Dräger D, Benecke R, Wree A. Antipova V, et al. Among authors: hawlitschka a. J Neurosci Res. 2013 Jun;91(6):838-47. doi: 10.1002/jnr.23210. Epub 2013 Mar 29. J Neurosci Res. 2013. PMID: 23553727

6

Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.

Maass F, Petersen J, Hovakimyan M, Schmitt O, Witt M, Hawlitschka A, Lukas J, Rolfs A, Wree A. Maass F, et al. Among authors: hawlitschka a. J Neurosci Res. 2015 Mar;93(3):433-42. doi: 10.1002/jnr.23509. Epub 2014 Nov 14. J Neurosci Res. 2015. PMID: 25400034

7

Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis.

Mehlan J, Brosig H, Schmitt O, Mix E, Wree A, Hawlitschka A. Mehlan J, et al. Among authors: hawlitschka a. Brain Res. 2016 Jan 1;1630:18-24. doi: 10.1016/j.brainres.2015.10.056. Epub 2015 Nov 10. Brain Res. 2016. PMID: 26562665

8

Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.

Antipova VA, Holzmann C, Schmitt O, Wree A, Hawlitschka A. Antipova VA, et al. Among authors: hawlitschka a. Front Behav Neurosci. 2017 Jun 21;11:119. doi: 10.3389/fnbeh.2017.00119. eCollection 2017. Front Behav Neurosci. 2017. PMID: 28680396 Free PMC article.

9

Intrastriatal administration of botulinum neurotoxin A normalizes striatal D₂ R binding and reduces striatal D₁ R binding in male hemiparkinsonian rats.

Wedekind F, Oskamp A, Lang M, Hawlitschka A, Zilles K, Wree A, Bauer A. Wedekind F, et al. Among authors: hawlitschka a. J Neurosci Res. 2018 Jan;96(1):75-86. doi: 10.1002/jnr.24110. Epub 2017 Jul 11. J Neurosci Res. 2018. PMID: 28695985

10

Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review.

Hawlitschka A, Wree A. Hawlitschka A, et al. Int J Mol Sci. 2018 May 7;19(5):1392. doi: 10.3390/ijms19051392. Int J Mol Sci. 2018. PMID: 29735936 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters